Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-06-26 @ 5:49 AM
Study NCT ID:
NCT04557956
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-24
First Post:
2020-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment
Sponsor:
National Cancer Institute (NCI)
Organization: